Trulieve Cannabis (TRLV) Asset Writedowns and Impairment (2021 - 2024)

Trulieve Cannabis (TRLV) has reported Asset Writedowns and Impairment for 4 consecutive years, with $477000.0 the latest figure, recorded in Q3 2024.

• In Q3 2024, Asset Writedowns and Impairment rose 139.45% year-over-year to $477000.0; the TTM figure through Sep 2024 stood at $2.2 million (up 105.53% YoY), while the FY2023 annual figure was $2.8 million, down 23.97% from the prior year.
• Asset Writedowns and Impairment came in at $477000.0 for Q3 2024 at Trulieve Cannabis, down from $5.8 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $54.6 million in Q3 2022, with the low at -$72.5 million in Q4 2022.
• Average Asset Writedowns and Impairment over 4 years is $1.7 million, with a median of $42000.0 recorded in 2022.
• The largest YoY upside for Asset Writedowns and Impairment was 1092880.0% in 2022 against a maximum downside of 1450860.0% in 2022.
• Year by year, Asset Writedowns and Impairment stood at $5000.0 in 2021, then plunged by 1450860.0% to -$72.5 million in 2022, then jumped by 96.24% to -$2.7 million in 2023, then soared by 117.47% to $477000.0 in 2024.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $477000.0, $5.8 million, and -$1.4 million for Q3 2024, Q2 2024, and Q1 2024 respectively.